Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,267 public trials 270 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Active, Not Recruiting

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

NCT04044768

Conditions
Liposarcoma, Liposarcoma, Myxoid, Myxoid Liposarcoma, +8 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Center Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib

NCT03673501

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • UCLA Hematology Oncology Center - Main Site Los Angeles, California, United States
  • Stanford Medicine Stanford, California, United States
View all 121 locations
View Trial Details
Active, Not Recruiting

Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)

NCT05417789

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
Locations
  • NextGen Oncology Beverly Hills, California, United States
  • Sarcoma Oncology Research Center, LLC Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Kansas Cancer Center (Overland Park) - USOR Overland Park, Kansas, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

NCT05071209

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)

NCT05245968

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Flinders Medical Center Adelaide, Australia
  • Alfred Health Melbourne, Australia
  • Beijing Cancer Hospital Beijing, China
  • Fudan University, Shanghai Cancer Center Shanghai, China
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

NCT05830084

Conditions
Ewing Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations
  • Queensland Children's Hospital Brisbane, Australia
  • Monash Children's Hospital Clayton, Australia
  • Royal Children's Hospital Parkville, Australia
  • Perth Children's Hospital Perth, Australia
View all 13 locations
View Trial Details
Active, Not Recruiting

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00565851

Conditions
Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 709 locations
View Trial Details

Related conditions